Michael A Sherrill from 88 E San Fernando St UNIT 2101, San Jose, CA 95113, age 45

view source

Location:

United States

view source

Location:

United States

Name / Title

Company / Classification

Phones & Addresses

Michael J Sherrill

FIDO PROPERTIES, LLC

Michael J. Sherrill

SIMPLIFIED FACILITIES GROUP, INC

Therapeutic Formulations
view source
US Patent:

7091193, Aug 15, 2006
Filed:

Oct 9, 2003
Appl. No.:

10/683952
Inventors:

Michael J. Sherrill - Danville CA, US
Assignee:

Kosan biosciences Incorporated - Hayward CA
International Classification:

A61K 31/724
A61K 31/715
C08B 37/16
US Classification:

514 58, 514365, 536103
Abstract:

Formulations comprising one or more epothilones together with a pharmaceutically acceptable carrier, in particular such pharmaceutical compositions suitable for oral administration of an epothilone.

Methods To Administer Epothilone D
view source
US Patent:

20040072882, Apr 15, 2004
Filed:

May 20, 2003
Appl. No.:

10/442820
Inventors:

Robert Johnson - Lafayette CA, US
Michael Sherrill - Danville CA, US
Alison Hannah - Sebastopol CA, US
Assignee:

Kosan Biosciences, Inc., A Delaware Corporation - Hayward CA
International Classification:

A61K031/427
US Classification:

514/365000
Abstract:

Methods to deliver epothilone D to subjects having tumorigenic diseases are provided. In some embodiments, the invention provides methods for treating tumor-bearing subjects with an intravenous infusion of epothilone D at least once about every seven days throughout a delivery period of about twenty-one consecutive day period

Therapeutic Formulations
view source
US Patent:

20050148543, Jul 7, 2005
Filed:

Oct 8, 2004
Appl. No.:

10/962308
Inventors:

Michael Sherrill - Danville CA, US
Robert Johnson - Lafayette CA, US
International Classification:

A61K031/724
A61K031/427
US Classification:

514058000, 514365000
Abstract:

Formulations comprising one or more epothilones together with a pharmaceutically acceptable carrier.